Clarkston Consulting
Skip to content

Merger and Acquisition Consulting

As the rate of merger and acquisition deals continues to build in life sciences, companies need to institutionalize the ability to quickly align strategy and process, and leverage technology to facilitate a fast integration.

Technology is the common denominator across all corporate functions.

Because of the important role technology plays in companies, IT’s role in the long-term success or failure of an M&A deal is more important than ever. Technology touches virtually all aspects of a company’s operations and is the common denominator among all corporate functions. Creating an integration strategy that establishes a reliable technology integration is vital to the overall success of any merger transaction.


If you have been through an IT integration related to the merger, acquisition, or divestiture of a life sciences company, you know that there are a lot of opportunities created for the business when you get it right.

The best practices that make an integration successful can be leveraged across transactions, even though every integration process is unique.

  • Merger, Acquisition, and Divestiture Integration Strategy
  • Program Management

Having a plan that addresses the cross-functional needs of the business, particularly meeting Quality and Regulatory standards, requires a proven plan and strategy.

  • Project Management
  • Technology Integration
  • Data Migration

Mergers, acquisitions, and divestitures are becoming common place for pharmaceuticals, biotech, and medical device. Creating a strategy and process that can be repeated, yet customized for each integration, is becoming an expectation of on the IT organization.

  • M&A Methodology/Playbook

What Our Clients Say

Associate Director, Quality Systems

Global Pharmaceutical Company

I found the work ethic to be different from other consulting firms that I have worked with such that all of the consultants from Clarkston work as if they are a part of my company.

We helped a global generics manufacturer through the acquisition process and subsequent systems integration with another major player in the generics market. As a result of our work with the client, we were able to successfully integrate the technology landscape with minimal disruptions resulting in a new IT infrastructure that gave the acquiring organization visibility into business systems and built-in flexibility and scalability for future M&A. To learn more, reach out to our M&A expert, Janel Firestein.

Contact Janel

Contact Us

Contact Us

  • Clarkston Consulting requests your contact information so we may accurately and effectively respond to your request, as well as share our research and content with you. To learn more, please visit our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.